CA
NZ
UK
AU
IND
US
HeartSciences Inc. (NASDAQ:HSCS) spent the past year selling hospitals on artificial-intelligence software that reads electrocardiograms. It now sits at the centre of a very different story: an all-stock merger that would hand roughly 95% of the company to Digital Currency Group and turn the …
QuoteMedia, Inc. (OTCQB:QMCI) rarely generates headlines. It is a small Arizona-based supplier of stock quotes, market data feeds and portfolio tools to brokerages,Fintechplatforms and corporate websites. This month it has drawn attention for a different reason: a long-standing outside shareholder has crossed the 10% …
Amaze Holdings, Inc. (NYSEAMERICAN:AMZE) has packed a lot into five weeks. Since 13 July the creator-commerce company has been halted by its own exchange, pushed through a 1-for-8Reverse Stock Splitwithout a shareholder vote, regained listing compliance and removed its chief executive.
BIO-key International, Inc. (NASDAQ:BKYI) has spent 2026 doing two hard things at once: repairing its standing on theNasdaqCapital Market after a listing scare, and chasing national-scale customers in banking, defence and government. On 13 August the Holmdel, New Jersey company put numbers to that …
Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) has compressed a year of corporate news into five weeks: positive mid-stage clinical data, a formal search for a partner to fund the expensive part, and quarterly accounts showing how little time it has to close that deal.
Tenon Medical, Inc. (NASDAQ:TNON) makes implants that fuse the sacroiliac joint, the load-bearing hinge where the base of the spine meets the pelvis and an under-diagnosed source of chronic lower-back pain. The Los Gatos, California company has spent six weeks growing sales faster than …
Reviva Pharmaceuticals Holdings, Inc. (OTCQB:RVPH) is a Cupertino, California clinical-stage drug developer whoseInvestmentcase rests almost entirely on one molecule: brilaroxazine, an experimental once-daily pill for schizophrenia.
IceCure Medical Ltd. (NASDAQ:ICCM), the Israeli developer of the ProSense liquid-nitrogen cryoablation system, is trying to prove a hard-won U.S. clearance can turn into revenue. On 12 August 2026 it reported first-half sales up about 45% year over year, its strongest growth since the …
Intensity Therapeutics, Inc. (NASDAQ:INTS) spent much of the past 18 months with both of its lead cancer studies standing still. One was halted for money, the other for safety. In July it began dosing patients again in the smaller of the two, and on …
Moleculin Biotech, Inc. (NASDAQ:MBRX) did two things on the same July morning that small drug developers usually do months apart: it released a fresh interim look at the most important trial it has ever run, and priced a stock sale to help pay for …
Please wait processing your request...